<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25886323</article-id><article-id pub-id-type="pmc">4258977</article-id><article-id pub-id-type="publisher-id">AER-8-291</article-id><article-id pub-id-type="doi">10.4103/0259-1162.143111</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Facilitation of fiberoptic nasotracheal intubation with magnesium sulfate: A double-blind randomized study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Elgebaly</surname><given-names>Ahmed Said</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Eldabaa</surname><given-names>Ahmed Ali</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anesthesia and PSICUD, Faculty of Medicine, Tanta University, Egypt</aff><author-notes><corresp id="cor1">
Corresponding author: Dr. Ahmed Said Elgebaly, Department of Anaesthesia and SICUD, 43 IBN Elfard Street, Elgharbia, Tanta, Egypt. E-mail: <email xlink:href="elgebaly_13@hotmail.com">elgebaly_13@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Dec</season><year>2014</year></pub-date><volume>8</volume><issue>3</issue><fpage>291</fpage><lpage>295</lpage><permissions><copyright-statement>Copyright: &#x000a9; Anesthesia: Essays and Researches</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>A double-blinded, prospective, and randomized study was designed to determine the efficacy and tolerability of intravenous (IV) magnesium sulfate (MgSO<sub>4</sub>) to facilitate fiberoptic bronchoscopic (FOB) nasotracheal intubations.</p></sec><sec id="st2"><title>Patients and Methods:</title><p>A total of 120 patients scheduled to undergo elective awake fiberoptic nasotracheal intubation, while they were anesthetized for elective surgery were randomly allocated to one of three groups: The control Group S (<italic>n</italic> = 40) received 100 ml (50 ml 0.9% saline + 50 ml paracetamol) was infused in 10 min and direct IV 5 ml 0.9% normal saline, Group MD (<italic>n</italic> = 40): Received midazolam IV in a dose of 0.07 mg/kg in 5 ml 0.9% normal saline and 100 ml 0.9% was infused in 10 min and Group MS (<italic>n</italic> = 40): IV 45 mg/kg MgSO<sub>4</sub> 10 min in 100 ml of 0.9% normal saline through 10 min and direct IV 5 ml 0.9% normal saline.</p></sec><sec id="st3"><title>Results:</title><p>Time required for nasotracheal intubation was significantly less in group Groups MD and MS, as compared with the control group, but not significant between the two groups. (Group MD: 9.05 + 1.95 min, Group MS 3.75 + 0.75 min and Group S 16.85 + 1.7 min). However, the number of fiberoptic intubation was significantly more in the MD and MS groups, as compared with the control group. Easy intubation (control group: 0, Group MD: 25 and Group MS: 35), moderate difficulty (control group: 5, Group MD: 12 and Group MS: 4) and difficult (control group: 35, Group MD: 3 and Group MS: 1). Procedure adverse events were significantly lower in Group MS. None of the patients in Group MS had procedure hypoxia, but it occurred in 10 patients of Group MD and 20 patients in Group S. Six patients in Group S and two in Group MD had procedure apnea whereas, none of the patients in the MS group experienced this. After medication and just before intubation heart rate and mean arterial pressure were significantly less in Groups MD and MS, as compared to the control group (Group MD: 77 + 7.7 beat/min, Group MS: 70 + 5.6 beat/min and Group S: 80 + 7.8 beat/min) (Group MD: 90 + 8.5 mmHg, Group MS: 80 + 8.1 mmHg and Group S: 105 + 10.5 mmHg). This difference however, significant between Group MD and Group MS.</p></sec><sec id="st4"><title>Conclusion:</title><p>Intravenous MgSO<sub>4</sub> improved awaken FOB intubation without adverse hemodynamic or respiratory effects.</p></sec></abstract><kwd-group><kwd>Fiberoptic</kwd><kwd>magnesium sulfate</kwd><kwd>nasotracheal intubation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Although passage of a tracheal tube over a fiberoptic bronchoscope has improved the ability to manage a difficult airway, however, this technique doesn&#x02019;t ensure successful intubation,[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] especially after topical anesthesia of the tongue and pharynx with lidocaine spray, patients cannot tolerate fiberoptic bronchoscopy with discomfort.[<xref rid="ref3" ref-type="bibr">3</xref>] The various audits of bronchoscopic practice have reported mortality rates of 0.01-0.5% and major complication rates of 0.08-5%, respectively.[<xref rid="ref4" ref-type="bibr">4</xref>] Most of deaths and major complications have been related to the sedative regimen used.[<xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] This has led to an increased awareness of the need for a satisfactory sedative regimen for fiberoptic usage.[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>]</p><p>The sedative drugs that were commonly used are opioids and benzodiazepine.[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] Magnesium (Mg) plays a fundamental role in many physiological process, for example neuronal activity, muscular contraction, and control of vasomotor tone. Mg is known to possess muscle relaxing effects, mostly by reducing, acetylcholine release, and it seems to have antinociceptive and anesthetics effects.[<xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref>]</p><p>We hypothesized that the administration of magnesium sulfate (MgSO<sub>4</sub>) could facilitate fiberoptic nasotracheal intubations.</p></sec><sec sec-type="methods" id="sec1-2"><title>PATIENTS AND METHODS</title><p>This study was carried out after obtaining approval from Institutional Ethical Committee. A written informed consent was obtained from 130 patients, ages ranged between 22 and 66 years of both sex and scheduled to undergo elective awake fiberoptic nasotracheal intubation while they were anesthetized for elective surgery from January 2013 to December 2013 patients, who declined to participate or had known abnormal laryngeal structures (e.g. tumors), infectious and toxic conditions of the neck and airway, and traumatic conditions of the neck other than cervical spine fractures or dislocations were excluded from the study.</p><p>During the preparation visit, an evaluation of the anatomy of the airway was done, according to Mallampati score classification.[<xref rid="ref16" ref-type="bibr">16</xref>] Furthermore, the data of awake intubation were explained. Peripheral cannula was inserted. Patients were classified into three groups (40 patients in each group).</p><p>
<list list-type="bullet"><list-item><p>Group S (<italic>n</italic> = 40): Received 100 ml (50 ml 0.9% saline + 50 ml paracetamol) was infused in 10 min and direct intravenous (IV) 5 ml 0.9% normal saline</p></list-item><list-item><p>Group MD (<italic>n</italic> = 40): received midazolam IV in a dose of 0.07 mg/kg[<xref rid="ref17" ref-type="bibr">17</xref>] in 5 ml 0.9% normal saline and 100 ml 0.9% was infused in 10 min</p></list-item><list-item><p>Group MS (<italic>n</italic> = 40): IV 45 mg/kg MgSO<sub>4</sub> 10 min in 100 ml of 0.9% normal saline through 10 min and direct IV 5 ml 0.9% normal saline.</p></list-item></list>
</p><p>All patients received 1 mg atropine sulfate IV and Afrin nasal decongestant drops in the right nostril. Topical anesthesia was achieved by nebulizer for 10 min using 10 ml lidocaine 2%.</p><p>After preparation of patients, nastroacheal tube (8 mm) was inserted through the right nostril into the oropharynx, and then well lubricated fiberoptic bronchoscope (STARZ 5-4 mm) was passed through the tube and manipulated to identify the epiglottis and cords. The bronchoscope was advanced into the trachea to the level of the carina, then the tube threaded over it.</p><p>The degree of difficulty of intubation was classified by an experienced observer according to the following.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><sec id="sec2-1"><title>Not difficult</title><p>If no manipulation of the tip of the scope was needed.</p></sec><sec id="sec2-2"><title>Moderately difficult</title><p>Moderate manipulation of the bronchoscope in all directions was necessary to locate the cords.</p></sec><sec id="sec2-3"><title>Difficult</title><p>It would be difficult to identify the cords extensive manipulation of the bronchoscope in all directions with change in position of the operator.</p><p>Furthermore, the intubations time was measured, which is the time from insertion of the bronchoscope to completion of intubation. All the medications were prepared by an anesthesiologist who was not involved in any other aspect of the study. All syringes were identical and had similar volumes of the test and placebo solutions. The investigator who administered the drug, the anesthesiologist who performed the procedure and the patients, were unaware of the group allocated and the drug that was received by the patient.</p></sec><sec id="sec2-4"><title>Monitoring</title><p>Mean arterial pressure (MAP), heart rate and oxyhemoglobin saturation (PO<sub>2</sub>) through pulse oximetry were monitored.</p><p>Hypoxemic episodes were defined as SPO<sub>2</sub> &#x0003c;90% and lasting &#x02265;10 s. Apnea was defined as the absence of spontaneous respiration for &#x0003e;15 s. If hypoxemia or apnea occurred, spontaneous respiration was encouraged by vocal or tactile stimuli.</p><p>If hypotension occurred (MAP decreased &#x02265;30% of baseline, 6 mg ephedrine was administrated. If heart rate decreased to &#x0003c;50 beat/min, 0.6 mg atropine sulfate IV was given.</p><p>In all patients to blow the secretions away from the tip of fiberoptic bronchoscopic (FOB), oxygen was insufflated through the suction port of the instrument (2 L/min).</p><p>The tip of FOB was immersed in warm saline (37&#x000b0;C) 1 min prior to insertion to prevent fogging.</p></sec><sec id="sec2-5"><title>Statistical analysis</title><p>The sample size was calculated to be <italic>N</italic> = 40 based on the following considerations: 95% confidence level, 80% power of the study. Equal size of the studied groups the estimated outcome to range between 50% and 80% between the studied groups. Statistical analysis was performed using one-way analysis of variance for normally distributed parametric data. Time required for nasotracheal intubation, procedure adverse events (case of FOB intubations, hypoxia, and apnea) were analyzed by the Kruskal-Wallis test followed by the <italic>post hoc</italic> multiple comparison tests using the Dunnett method. <italic>P</italic> &#x0003c; 0.05 was considered as statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>A total of 130 patients were randomized into the study, of which ten patients were excluded. Of these, six patients had inadequate anesthesia and were given general anesthesia. Four patients went into active vomiting leading to prolong the procedure time. Statistical analysis was performed in the remaining 120 patients, 40 in each group.</p><p>There was no statistically significant difference between the groups as regard to patient demography and hemodynamics before the procedure [Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T3">3</xref>]. The time required for nasotracheal intubation was significantly less in the Groups MD and MS, as compared with the control Group S. (Group MD: 9.05 + 1.95 min, Group MS: 3.75 + 0.75 min and Group S: 16.85 + 1.7 min). This difference however, significant between Groups MD and MS [<xref ref-type="table" rid="T2">Table 2</xref>]. The number of fiberoptic intubation was significantly more in the MD and MS groups, as compared to the control group. Easy (control group: 0, Group MD: 25 and Group MS: 35), moderate difficulty (control group: 5, Group MD: 12 and Group MS: 4) and difficult (control group: 35, Group MD: 3 and Group MS: 1) [<xref ref-type="table" rid="T3">Table 3</xref>]. Procedure adverse events were significantly lower in Group MS as compared to Group S and Group MD. 20 patients in Group S and ten in Group MD had procedure hypoxia, six patients in Group S and two in Group MD had procedure apnea whereas, none of the patients in the MS group experienced this [<xref ref-type="table" rid="T3">Table 3</xref>]. After medication and just before intubation heart rate was significantly less in the group in Groups MD and MS, as compared to the control group (Group MD: 77 + 7.7beat/min, Group MS 70 + 5.6 beat/min and Group S 80 + 7.8 beat/min). This difference, however, significant between Group MD and Group MS. MAP was significantly less in the groups MD and MS, as compared to the control group. (Group MD: 90 + 8.5 mmHg, Group MS 80 + 8.1 mmHg and Group S 105 + 10.5 mmHg). This difference however, significant between Groups MD and MS.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic data</p></caption><graphic xlink:href="AER-8-291-g001"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Intubation time (min)</p></caption><graphic xlink:href="AER-8-291-g002"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Procedure adverse events</p></caption><graphic xlink:href="AER-8-291-g003"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Midazolam is a water soluble benzodiazepine with an elimination half-life of about 2 h and a rapid onset and a short duration of action in normal subjects.[<xref rid="ref17" ref-type="bibr">17</xref>] Its primary metabolite is pharmacologically active. Elderly patients are extremely sensitive to midazolam and extreme caution is recommended with its in elderly.[<xref rid="ref3" ref-type="bibr">3</xref>] Midazolam caused respiratory depression. With low doses the decreased tidal volume is compensated for by an increased respiratory rate, with larger doses, this compensation mechanism is lost, and hypoxemia or apnea may occur.[<xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref>]</p><p>A total of 1615 adverse events after use of Midazolam have been reported to the department of health and human services as a June 27, 1989. The dose of Midazolam report eddy administrated most often ranged from 1 to 10 mg. These reactions ranged from Hiccup to death. The most frequently reported adverse reaction was apnea, hypoxia or cyanosis. Fifty times reported from a total of 86 deaths occurred in the adverse drug reaction reported in US.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>This study shows that IV MgSO<sub>4</sub> 45 mg/kg improved awaken FOB intubation without adverse hemodynamic or respiratory effects.</p><p>The mechanism of action of Mg appears to be multifactorial. It has analgesic, anesthetic and muscle relaxant effects.[<xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Magnesium is the 4<sup>th</sup> most abundant cation in the body and the 2<sup>nd</sup> most an abundant intracellular cation.[<xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] It acts as a natural Ca<sup>+</sup> = antagonist regulating Ca<sup>++</sup> access into the cell[<xref rid="ref19" ref-type="bibr">19</xref>] it has the potential to treat and prevent pain by acting as an antagonist at N-methyl-D-aspartate receptors.[<xref rid="ref20" ref-type="bibr">20</xref>]</p><p>The study of tramer <italic>et al</italic>.[<xref rid="ref20" ref-type="bibr">20</xref>] showed the value of Mg as adjuvant in postoperative analgesia. Patients receiving Mg required less morphine had less discomfort and sleep better during 1<sup>st</sup> 48 h than those receiving morphine alone. Three respiratory depressions occurred in the group receiving morphine only versus none in the group treated with morphine and Mg. Koini <italic>et al</italic>.[<xref rid="ref21" ref-type="bibr">21</xref>] have reported similar results, with a reduced analgesic use both intra- and post-operatively.</p><p>Magnesium is considered to be a muscle relaxant like agent. Neuromuscular transmission isolated by reduction in the release of acetylcholine at motor nerve terminal.[<xref rid="ref15" ref-type="bibr">15</xref>] A clinical study demonstrated that a rapid infusion of MgSO<sub>4</sub> (50 mg/kg) can re-establish relevant degree of muscle paralysis in patients who have just recovered from nondepolarizing blocking agents.[<xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref>]</p><p>In patients with Tetanus MgSO infused at doses providing serum concentrations of 2-4 mmol/L allowed good control of spasm and muscle rigidity.[<xref rid="ref24" ref-type="bibr">24</xref>]</p><p>Magnesium decreases the amount of acetylcholine released from motor nerve terminal, leading to diminished exact ability of the muscle fiber itself and reduction in the amplitude of the end plate potential. It therefore, potentiates the nondepolarizing neuromuscular blocking agents.[<xref rid="ref25" ref-type="bibr">25</xref><xref rid="ref26" ref-type="bibr">26</xref>]</p><p>Magnesium decreases catecholamine release from the adrenal medulla and adrenergic nerve endings it obtunds the pressor response to laryngoscopy and intubation.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Choi <italic>et al</italic>.[<xref rid="ref25" ref-type="bibr">25</xref>] concluded that IV Mg SO4 reduced propofol infusion requirements. It could be related to the sedative effect of Mg. Mg has been reported to produce general anesthesia and to enhance the activity of local anesthetic agents.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>A narcotic state inhuman being undergoing surgical operations was achieved in a study by Peck and Meltzer who reported three patients. Undergoing hernioplasty under attempted anesthesia by MgSO<sub>4</sub> infusion.[<xref rid="ref18" ref-type="bibr">18</xref>]</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Fiberoptic bronchoscopic tracheal intubation in MgSO<sub>4</sub> group was easier faster and without hemodynamic or respiratory adverse effects as compared with midazolam group.</p><p>Hence, we recommend IV MgSO<sub>4</sub> to facilitate awaken FOB tracheal intubations.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DM</given-names></name><name><surname>From</surname><given-names>AM</given-names></name><name><surname>Smith</surname><given-names>RB</given-names></name><name><surname>From</surname><given-names>RP</given-names></name><name><surname>Maktabi</surname><given-names>MA</given-names></name></person-group><article-title>Endoscopic study of mechanisms of failure of endotracheal tube advancement into the trachea during awake fiberoptic orotracheal intubation</article-title><source>Anesthesiology</source><year>2005</year><volume>102</volume><fpage>910</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">15851876</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovassapian</surname><given-names>A</given-names></name><name><surname>Yelich</surname><given-names>SJ</given-names></name><name><surname>Dykes</surname><given-names>MH</given-names></name><name><surname>Brunner</surname><given-names>EE</given-names></name></person-group><article-title>Fiberoptic nasotracheal intubation - Incidence and causes of failure</article-title><source>Anesth Analg</source><year>1983</year><volume>62</volume><fpage>692</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">6859572</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundra</surname><given-names>P</given-names></name><name><surname>Kutralam</surname><given-names>S</given-names></name><name><surname>Ravishankar</surname><given-names>M</given-names></name></person-group><article-title>Local anaesthesia for awake fibreoptic nasotracheal intubation</article-title><source>Acta Anaesthesiol Scand</source><year>2000</year><volume>44</volume><fpage>511</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10786733</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>D</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Roberts</surname><given-names>J</given-names></name></person-group><article-title>A maneuver to facilitate flexible fiberoptic intubation</article-title><source>Anesthesiology</source><year>1989</year><volume>71</volume><fpage>470</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">2774282</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>FS</given-names></name><name><surname>He</surname><given-names>N</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>XZ</given-names></name><name><surname>Xu</surname><given-names>YC</given-names></name><name><surname>Yang</surname><given-names>QY</given-names></name><etal/></person-group><article-title>Clinical assessment of awake endotracheal intubation using the lightwand technique alone in patients with difficult airways</article-title><source>Chin Med J (Engl)</source><year>2009</year><volume>122</volume><fpage>408</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">19302746</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenstock</surname><given-names>CV</given-names></name><name><surname>Th&#x000f8;gersen</surname><given-names>B</given-names></name><name><surname>Afshari</surname><given-names>A</given-names></name><name><surname>Christensen</surname><given-names>AL</given-names></name><name><surname>Eriksen</surname><given-names>C</given-names></name><name><surname>G&#x000e4;tke</surname><given-names>MR</given-names></name></person-group><article-title>Awake fiberoptic or awake video laryngoscopic tracheal intubation in patients with anticipated difficult airway management: A randomized clinical trial</article-title><source>Anesthesiology</source><year>2012</year><volume>116</volume><fpage>1210</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22487805</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>ST</given-names></name><name><surname>Schleich</surname><given-names>AR</given-names></name></person-group><article-title>Airway regional anesthesia for awake fiberoptic intubation</article-title><source>Reg Anesth Pain Med</source><year>2002</year><volume>27</volume><fpage>180</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11915066</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frerk</surname><given-names>CM</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name></person-group><article-title>Laryngoscopy: Time to change our view</article-title><source>Anaesthesia</source><year>2009</year><volume>64</volume><fpage>351</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">19317697</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukomsky</surname><given-names>GI</given-names></name><name><surname>Ovchinnikov</surname><given-names>AA</given-names></name><name><surname>Bilal</surname><given-names>A</given-names></name></person-group><article-title>Complications of bronchoscopy: Comparison of rigid bronchoscopy under general anesthesia and flexible fiberoptic bronchoscopy under topical anesthesia</article-title><source>Chest</source><year>1981</year><volume>79</volume><fpage>316</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">7471862</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>FG</given-names></name><name><surname>Arnold</surname><given-names>AG</given-names></name><name><surname>Purvis</surname><given-names>A</given-names></name><name><surname>Belfield</surname><given-names>PW</given-names></name><name><surname>Muers</surname><given-names>MF</given-names></name><name><surname>Cooke</surname><given-names>NJ</given-names></name></person-group><article-title>Postal survey of bronchoscopic practice by physicians in the United Kingdom</article-title><source>Thorax</source><year>1986</year><volume>41</volume><fpage>311</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3738850</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>SJ</given-names></name></person-group><article-title>Fibreoptic bronchoscopy: Is sedation necessary?</article-title><source>Br Med J</source><year>1980</year><volume>281</volume><fpage>779</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">7427446</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rees</surname><given-names>PJ</given-names></name><name><surname>Hay</surname><given-names>JG</given-names></name><name><surname>Webb</surname><given-names>JR</given-names></name></person-group><article-title>Premedication for fibreoptic bronchoscopy</article-title><source>Thorax</source><year>1983</year><volume>38</volume><fpage>624</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">6351333</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herroeder</surname><given-names>S</given-names></name><name><surname>Sch&#x000f6;nherr</surname><given-names>ME</given-names></name><name><surname>De Hert</surname><given-names>SG</given-names></name><name><surname>Hollmann</surname><given-names>MW</given-names></name></person-group><article-title>Magnesium-Essentials for anesthesiologists</article-title><source>Anesthesiology</source><year>2011</year><volume>114</volume><fpage>971</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">21364460</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dub&#x000e9;</surname><given-names>L</given-names></name><name><surname>Granry</surname><given-names>JC</given-names></name></person-group><article-title>The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: A review</article-title><source>Can J Anaesth</source><year>2003</year><volume>50</volume><fpage>732</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">12944451</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawcett</surname><given-names>WJ</given-names></name><name><surname>Haxby</surname><given-names>EJ</given-names></name><name><surname>Male</surname><given-names>DA</given-names></name></person-group><article-title>Magnesium: Physiology and pharmacology</article-title><source>Br J Anaesth</source><year>1999</year><volume>83</volume><fpage>302</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">10618948</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mallampati</surname><given-names>SR</given-names></name><name><surname>Gatt</surname><given-names>SP</given-names></name><name><surname>Gugino</surname><given-names>LD</given-names></name><name><surname>Desai</surname><given-names>SP</given-names></name><name><surname>Waraksa</surname><given-names>B</given-names></name><name><surname>Freiberger</surname><given-names>D</given-names></name><etal/></person-group><article-title>A clinical sign to predict difficult tracheal intubation: A prospective study</article-title><source>Can Anaesth Soc J</source><year>1985</year><volume>32</volume><fpage>429</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">4027773</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="book"><article-title>Roche Product Ltd. Midazolam (Hypnovel) Data Sheet</article-title><year>1989</year><publisher-loc>Wlwexn Gerden City</publisher-loc><publisher-name>Roche</publisher-name></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peck</surname><given-names>CH</given-names></name><name><surname>Meltzer</surname><given-names>SJ</given-names></name></person-group><article-title>Anaesthsia in Humman beings by I.V. Injeciton of MgSO4</article-title><source>J Am Med Assoc</source><year>1916</year><volume>601</volume><fpage>1131</fpage><lpage>3</lpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iseri</surname><given-names>LT</given-names></name><name><surname>French</surname><given-names>JH</given-names></name></person-group><article-title>Magnesium: Nature's physiologic calcium blocker</article-title><source>Am Heart J</source><year>1984</year><volume>108</volume><fpage>188</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">6375330</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tramer</surname><given-names>MR</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Marti</surname><given-names>RA</given-names></name><name><surname>Rifat</surname><given-names>K</given-names></name></person-group><article-title>Role of magnesium sulfate in postoperative analgesia</article-title><source>Anesthesiology</source><year>1996</year><volume>84</volume><fpage>340</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8602664</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koinig</surname><given-names>H</given-names></name><name><surname>Wallner</surname><given-names>T</given-names></name><name><surname>Marhofer</surname><given-names>P</given-names></name><name><surname>Andel</surname><given-names>H</given-names></name><name><surname>H&#x000f6;rauf</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>N</given-names></name></person-group><article-title>Magnesium sulfate reduces intra-and postoperative analgesic requirements</article-title><source>Anesth Analg</source><year>1998</year><volume>87</volume><fpage>206</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">9661575</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hans</surname><given-names>GA</given-names></name><name><surname>Bosenge</surname><given-names>B</given-names></name><name><surname>Bonhomme</surname><given-names>VL</given-names></name><name><surname>Brichant</surname><given-names>JF</given-names></name><name><surname>Venneman</surname><given-names>IM</given-names></name><name><surname>Hans</surname><given-names>PC</given-names></name></person-group><article-title>Intravenous magnesium re-establishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium: A randomised controlled trial</article-title><source>Eur J Anaesthesiol</source><year>2012</year><volume>29</volume><fpage>95</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">22183158</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attygalle</surname><given-names>D</given-names></name><name><surname>Rodrigo</surname><given-names>N</given-names></name></person-group><article-title>Magnesium as first line therapy in the management of tetanus: A prospective study of 40 patients</article-title><source>Anaesthesia</source><year>2002</year><volume>57</volume><fpage>811</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12133096</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Savarenese</surname><given-names>JJ</given-names></name><name><surname>Cadwell</surname><given-names>JE</given-names></name><name><surname>Lien</surname><given-names>CA</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Miler</surname><given-names>RD</given-names></name></person-group><article-title>Phamraoclogy of muscle relaxants and their antognists</article-title><source>Anesthesia</source><year>2000</year><edition>5th ed</edition><publisher-loc>Philadelphia</publisher-loc><publisher-name>Churchill Living Stone</publisher-name><fpage>463</fpage></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JC</given-names></name><name><surname>Yoon</surname><given-names>KB</given-names></name><name><surname>Um</surname><given-names>DJ</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>SG</given-names></name></person-group><article-title>Intravenous magnesium sulfate administration reduces propofol infusion requirements during maintenance of propofol-N2O anesthesia: Part I: Comparing propofol requirements according to hemodynamic responses: Part II: Comparing bispectral index in control and magnesium groups</article-title><source>Anesthesiology</source><year>2002</year><volume>97</volume><fpage>1137</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">12411798</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltzer</surname><given-names>SJ</given-names></name><name><surname>Auer</surname><given-names>J</given-names></name></person-group><article-title>Physiological and pharmaoclogical studies on magn salts. II. Narcotizing effects of magn salts upon nerve fibers</article-title><source>Am J Physiol</source><year>1906</year><volume>16</volume><fpage>233</fpage><lpage>8</lpage></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutinho</surname><given-names>EM</given-names></name></person-group><article-title>Calcium, magnesium, and local anesthesia</article-title><source>J Gen Physiol</source><year>1966</year><volume>49</volume><fpage>845</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">5943618</pub-id></element-citation></ref></ref-list></back></article>